4612 Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices 

investigation on the basis of two 

settlement agreements. 

FOR FURTHER INFORMATION CONTACT: 

Steven Crabb, Esq., Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street, SW., 

Washington, DC 20436, telephone (202) 

708–5432. Copies of non-confidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street, SW., Washington, DC 20436, 

telephone (202) 205–2000. General 

information concerning the Commission 

may also be obtained by accessing its 

Internet server (http://www.usitc.gov). 

The public record for this investigation 

may be viewed on the Commission’s 

electronic docket (EDIS) at http:// 

edis.usitc.gov. Hearing-impaired 

persons are advised that information on 

this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. 

SUPPLEMENTARY INFORMATION: This 

investigation was instituted by the 

Commission based on a complaint filed 

by BenQ Corporation of Taiwan and 

BenQ America Corporation of Irvine, 

California. See 70 FR 35453 (June 20, 

2005). The complaint alleged violations 

of section 337 of the Tariff Act of 1930 

in the importation into the United 

States, the sale for importation, and the 

sale in the United States after 

importation of certain DVD/CD players 

and recorders, color television receivers 

and monitors, and components thereof 

by reason of infringement of claims 7–

11 and 13–15 of U.S. Patent No. 

5,270,821, and claims 1, 2, 4, and 5 of 

U.S. Patent No. 6,683,842. The 

complaint named Thomson Inc. of 

Indianapolis, Indiana as the respondent. 

On December 9, 2005, the private 

parties filed a joint motion to terminate 

the investigation on the basis of two 

settlement agreements. On December 14, 

2005, the Commission investigative 

attorney filed a response in support of 

the parties’ joint motion to terminate the 

investigation. 

On December 21, 2005, the ALJ issued 

an ID (Order No. 16) granting the joint 

motion to terminate the investigation on 

the basis of the settlement agreements. 

The ALJ found no indication that such 

termination of the investigation would 

adversely impact the public interest. No 

party filed a petition to review the 

subject ID. 

The Commission has determined not 

to review the ALJ’s ID. Accordingly, the 

above-referenced investigation is hereby 

terminated. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in 

sections 210.21(b), and 210.42 of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 210.21, 210.42). 

By order of the Commission. 

Issued: January 23, 2006. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. E6–1038 Filed 1–26–06; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[USITC SE–06–009] 

Sunshine Act Meeting 

AGENCY HOLDING THE MEETING: United 

States International Trade Commission. 

TIME AND DATE: February 8, 2006 at 11 

a.m. 

PLACE: Room 101, 500 E Street, SW., 

Washington, DC 20436, Telephone: 

(202) 205–2000. 

STATUS: Open to the public. 

MATTERS TO BE CONSIDERED: 

1. Agenda for future meetings: none. 

2. Minutes. 

3. Ratification List. 

4. Inv. No. 731–TA–1089 (Final)(Certain 

Orange Juice from Brazil)—briefing 

and vote. (The Commission is 

currently scheduled to transmit its 

determination and Commissioners’

opinions to the Secretary of 

Commerce on or before February 21, 

2006.) 

5. Outstanding action jackets: None. 

In accordance with Commission 

policy, subject matter listed above, not 

disposed of at the scheduled meeting, 

may be carried over to the agenda of the 

following meeting. 

Issued: January 25, 2006. 

By order of the Commission. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. 06–866 Filed 1–25–06; 3:48 pm] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in Schedule I or II and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2)(B) authorizing the importation 

of such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on August 

17, 2005, Cerilliant Corporation, 811 

Paloma Drive, Suite A, Round Rock, 

Texas 78664, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in Schedule 

I and II: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

N-Ethylamphetamine (1475) ........ I 

Gamma hydroxybutyric acid 

(2010).

I 

Ibogaine (7260) ............................ I 

Tetrahydrocannabinols (7370) ..... I 

Mescaline (7381) .......................... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

3,4- 

Methylenedioxymethamphetamine (7404).

I 

3,4- 

Methylenedioxymethamphetamine (7405).

I 

4-Methoxyamphetamine (7411) ... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

Etorphine (9056) ........................... I 

Heroin (9200) ............................... I 

Pholcodine (9314) ........................ I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Benzoylecgonine (9180) ............... II 

Ethylmorphine (9190) ................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

The company plans to import small 

quantities of the listed controlled 


rmajette on PROD1PC67 with NOTICES